Indonesia vs Tunisia: Access to anti-retroviral drugs, female
Indonesia
36.0%
in 2024
Tunisia
33.0%
in 2024
Indonesia rank
130th
Tunisia rank
133rd
Access to anti-retroviral drugs, female over time
- Indonesia
- Tunisia
How they compare
Indonesia currently reports 36.0% against 33.0% in Tunisia, a difference of 3.0%.
That makes Indonesia's figure about 1.1 times Tunisia's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Tunisia ahead.
Indonesia ranks 130th and Tunisia ranks 133rd of 141 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Indonesia | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.3% | 4.4% | 3.1% | Tunisia |
| 2010s | 12.9% | 19.9% | 7.0% | Tunisia |
| 2020s | 28.8% | 33.8% | 5.0% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Indonesia or Tunisia?
- Indonesia, at 36.0% against 33.0% in Tunisia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Indonesia and Tunisia?
- 3.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Indonesia and Tunisia rank globally for access to anti-retroviral drugs, female?
- Indonesia ranks 130th and Tunisia ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.